1. Home
  2. CTVA vs RMD Comparison

CTVA vs RMD Comparison

Compare CTVA & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corteva Inc.

CTVA

Corteva Inc.

HOLD

Current Price

$72.87

Market Cap

44.7B

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$258.15

Market Cap

36.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTVA
RMD
Founded
2018
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.7B
36.4B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
CTVA
RMD
Price
$72.87
$258.15
Analyst Decision
Strong Buy
Buy
Analyst Count
17
12
Target Price
$78.38
$291.10
AVG Volume (30 Days)
3.5M
846.0K
Earning Date
02-03-2026
01-29-2026
Dividend Yield
0.99%
0.94%
EPS Growth
139.00
29.59
EPS
2.35
9.77
Revenue
$17,469,000,000.00
$5,257,400,000.00
Revenue This Year
$6.91
$9.88
Revenue Next Year
$3.56
$7.37
P/E Ratio
$31.09
$26.15
Revenue Growth
5.00
9.36
52 Week Low
$53.40
$199.92
52 Week High
$77.41
$293.81

Technical Indicators

Market Signals
Indicator
CTVA
RMD
Relative Strength Index (RSI) 69.09 57.05
Support Level $68.42 $250.19
Resistance Level $72.30 $264.09
Average True Range (ATR) 1.34 5.98
MACD 0.28 0.27
Stochastic Oscillator 90.96 65.52

Price Performance

Historical Comparison
CTVA
RMD

About CTVA Corteva Inc.

Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva plans to spin off its seeds business in 2026 and will become a pure-play crop protection company following the divestiture. Corteva operates globally, but around half of revenue comes from North America.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: